ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Long-Term Kidney Graft Survival is Superior with Simultaneous-Liver Kidney (SLK) Transplants Than Kidney Alone (KA) or Kidney after Liver (KALi) Transplants in the United States

    N. Lim1, S. M. Riad1, S. Jackson2, J. Lake1

    1University of Minnesota, Minneapolis, MN, 2M Health Fairview, Minneapolis, MN

    *Purpose: There is a concern that SLK transplant recipients have worse outcomes resulting in poor utilization of the kidney donor pool. We utilized the Scientific…
  • 2020 American Transplant Congress

    High PRA Increases Rejection but Does Not Worsen Renal Function in the First Year Post Kidney Transplant with Alemtuzumab Induction

    B. Wise, A. Freeman, M. Janusek, S. Anders, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez

    Ochsner Medical Center, New Orleans, LA

    *Purpose: Sensitization is an important immunologic risk factor considered in renal allograft allocation and influences immunosuppression. Unfortunately, there is a lack of consensus regarding the…
  • 2020 American Transplant Congress

    Enough Initial Tacrolimus Blood Concentration is Crucial Even with Additional Everolimus in Corticosteroid Early Withdrawal Regimen for Kidney Transplant Recipients

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, 2Pharmacy, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: Everolimus (EVR) in combination with low-dose calcineurin inhibitor has been demonstrated in clinical trials to have comparable efficacy in low immunological risk kidney transplant…
  • 2020 American Transplant Congress

    Anti-T Lymphocyte Immunoglobulins versus Basiliximab in Highly Sensitized Kidney-Transplant Patients without Preformed DSAs: The Satir Study

    N. Kamar1, L. Couzi2, L. Albano3, A. Durrbach4, V. Pernin5, L. Esposito1, M. Lequintrec5, P. Merville2, A. Del Bello1

    1Toulouse University Hospital, Toulouse, France, 2Bordeaux University Hospital, Bordeaux, France, 3Nice University Hospital, Nice, France, 4Henri Mondor University Hospital, Paris, France, 5Montpellier University Hospital, Montpellier, France

    *Purpose: Two prospective studies that were performed before the era of highly sensitive solid-phase assays have shown a lower incidence of acute rejection in highly…
  • 2020 American Transplant Congress

    Basiliximab Induction in the Obese: One Size Does Fit All

    A. D. Reticker1, D. Choi1, A. B. Lichvar1, C. Kane2, I. Tzvetanov3, E. Benedetti3, J. J. Benken1

    1Pharmacy Practice, University of Illinois Hospital and Health Sciences System, Chicago, IL, 2Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 3Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL

    *Purpose: Surgical advancements allow more obese (BMI> 30 kg/m2) patients to receive a renal transplant. The original clinical and pharmacokinetic (PK) trials in transplantation immunosuppression…
  • 2020 American Transplant Congress

    Does the Distance from the Transplant Center Impact Kidney Transplant (KT) DGF, CIT and Outcomes?

    M. Laftavi1, O. Pankewycz2, R. Shahbazov1, A. Almonte1, B. Gallay2, J. Leggat2, R. Hod Dvorai1, C. Hubbell1, S. Narsipur2

    1Transplant, Upstate Medical University, SYRACUSE, NY, 2Nephrology, Upstate Medical University, SYRACUSE, NY

    *Purpose: Currently, there is an ongoing debate regarding the efficient use of available organs (utility) versus the fair access to transplant (equity). UNOS is now…
  • 2020 American Transplant Congress

    Impact of Kidney Allocation System on Waiting List Outcomes for Candidates Listed in Veterans Affairs Programs

    J. Walker1, B. Concepion2, K. Birdwell2, I. Feurer3, S. Rega4, D. Shaffer5, R. Forbes5

    1Surgery, Vanderbilt University Medical Center (VUMC), Nashville, TN, 2Nephrology, VUMC, Nashville, TN, 3Surgery and Biostatistics, VUMC, Nashville, TN, 4Transplant Center, VUMC, Nashville, TN, 5Surgery, Division of Kidney and Pancreas Transplantation, VUMC, Nashville, TN

    *Purpose: Kidney Allocation System (KAS) changes in 2014 prioritized highly sensitized candidates and aimed to improve longevity matching. Given that veterans are older and less…
  • 2020 American Transplant Congress

    Renal Transplant Induction Therapy Safety Outcomes Comparison

    R. M. Hofmann1, J. Combs2, K. J. Schmidt3, T. Dyckman4

    1Nephrology, Renal Associates of West Michigan, Grand Rapids, MI, 2Pharmacy/Transplant, Mercy Health St. Mary's, Grand Rapids, MI, 3Pharmacy, Ferris State University College of Pharmacy, Big Rapids, MI, 4Pharmacy, Mercy Health St. Mary's, Grand Rapids, MI

    *Purpose: Induction immunosuppression with alemtuzumab and rabbit anti-thymocyte globulin (r-ATG) reduces acute rejection following kidney transplantation. Efficacy is thought to be similar between the agents…
  • 2020 American Transplant Congress

    Prevalence of Risk Factors for NAFLD among Living Liver Donors

    D. A. Axelrod1, M. Simpson2, E. Pomfret3, A. Ehrlich4, S. Rwema4, R. Chung4, F. Gordon5

    1Surgery, University of Iowa, Iowa CIty, IA, 2Surgery, Lahey Clinic, Burlington, MA, 3University of Colorado, Denver, CA, 4Mass General Hospital, Boston, MA, 5Lahey, Burlington, MA

    *Purpose: The development of non-alcoholic fatty liver (NAFLD) disease has been strongly associated with the presence of polymorphisms in PNPLA3 rs738409. When compared with wild…
  • 2020 American Transplant Congress

    Transpulmonary Gradient as a Predictor for Outcomes after Single Lung Transplantation in Patients with Pulmonary Hypertension

    A. Madde1, E. Chan2, J. Ryan2, P. Reck Dos Santos2, M. Morrell3, J. Luketich2, P. Sanchez2

    1University of Pittsburgh School of Medicine, Pittsburgh, PA, 2UPMC Department of Cardiothoracic Surgery, Pittsburgh, PA, 3UPMC Division of Pulmonary Medicine, Pittsburgh, PA

    *Purpose: End stage lung disease is commonly associated with pulmonary artery hypertension (PAH). In a donor restrictive environment, offering patients single over double lung transplants…
  • « Previous Page
  • 1
  • …
  • 381
  • 382
  • 383
  • 384
  • 385
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences